Skip to main content
Terug
Watch Compare

Greenwich LifeSciences, Inc.

Datakwaliteit: 83%
GLSI
NASDAQ Manufacturing Chemicals
€ 25,78
▼ € 0,04 (-0,15%)
Marktkapitalisatie: 355,09 M
Prijs
€ 25,63
Marktkapitalisatie
355,09 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -8,59 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-1074,68%
Onder sectorgemiddelde (-54,44%)
ROIC-853,85%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Waardering

PE (TTM)
-18,23
Onder sectorgemiddelde (-1,49)
P/B Ratio162,52
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -18,2 -1,5
P/B 162,5 1,6
ROE % -1074,7 -54,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 25,78
+84.3%
Koersdoel
€ 47,50
€ 45,00
€ 47,50
€ 50,00
Vooruitzicht
Forward WPA -€ 1,35
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 -€ 1,35
-€ 1,48 – -€ 1,21
 0,0 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q32025 -€ 0,36 -€ 0,30 +16,7%
Q22025 -€ 0,24 -€ 0,30 -25,0%
Q12025 -€ 0,24 -€ 0,25 -4,2%
Q42024 -€ 0,21 -€ 0,61 -190,5%

ETFs Holding This Stock

GSCOX GSCOX
0,02% weight
GSIOX GSIOX
0,02% weight
GSTOX GSTOX
0,02% weight
GSROX GSROX
0,02% weight
GINUX GINUX
0,02% weight
GSZPX GSZPX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -19,48 M
ROE -1074,68% ROA -561,90%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8,59 M
ROIC -853,85% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value 2,18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -18,23 Forward P/E N/A
P/B Ratio 162,52 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2,42%
Market Cap 355,09 M Enterprise Value 351,28 M
Per Share
EPS (Diluted TTM) -1,46 Revenue / Share N/A
FCF / Share -0,62 OCF / Share -0,62
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 44,11%
SBC-Adj. FCF -13,82 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -15,79 M -8,89 M -7,83 M -4,57 M -1,86 M
EPS (Diluted) -1,21 -0,69 — — —
Gross Profit — — — — —
Operating Income -16,01 M -9,33 M -8,04 M -4,60 M -1,86 M
EBITDA — — — — —
R&D Expenses 12,95 M 7,70 M 6,48 M 3,56 M 1,06 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 4,09 M 6,99 M 13,48 M 27,22 M 28,68 M
Total Liabilities 1,56 M 294.406,0 262.905,0 385.172,0 1,05 M
Shareholders' Equity 2,53 M 6,70 M 13,21 M 26,83 M 27,63 M
Total Debt — — — — —
Cash & Equivalents 4,09 M 6,99 M 13,47 M 27,20 M 28,66 M
Current Assets — — — — 28,66 M
Current Liabilities 1,56 M 294.406,0 262.905,0 385.172,0 1,05 M